Fingerprint
Dive into the research topics of 'An FDA perspective on the regulatory implications of complex signatures to predict response to targeted therapies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An FDA perspective on the regulatory implications of complex signatures to predict response to targeted therapies
Julia A. Beaver, Abraham Tzou, Gideon M. Blumenthal, Amy E. McKee, Geoffrey Kim, Richard Pazdur, Reena Philip
Research output: Contribution to journal › Review article › peer-review
22
Scopus
citations